Ablynx competitorsClear all

Ablynx's top competitors include ImmunoGen, CytomX Therapeutics and Genfit.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Ablynx
Ablynx
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
ImmunoGen
ImmunoGen
ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
CytomX Therapeutics
CytomX Therapeutics
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
Genfit
Genfit
GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.
Founding Date
Founding Date
2001
Founding Date
1981
Founding Date
2008
Founding Date
1999
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Gent, BE HQ
Locations
Waltham, US HQ
Locations
South San Francisco, US HQ
Locations
Loos, FR HQ
Cambridge, US
Employees
Employees
3741% increase
Employees
795% increase
Employees
15815% increase
Employees
130
Valuation ($)
Valuation ($)
N/A
Valuation ($)
1.1 b
Valuation ($)
457.4 m
Valuation ($)
168.5 m
Twitter followers
Twitter followers
274
Twitter followers
1 k
Twitter followers
962
Twitter followers
3.5 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
4
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1.3
Average likes per tweet (last 30 days)
3
Average likes per tweet (last 30 days)
3.5
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
75%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
303177
Alexa Website Rank
347375
Alexa Website Rank
604494
Alexa Website Rank
168134
Employee Rating
Employee Rating
3.2
Employee Rating
3.3
Employee Rating
3.3
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
€85.2m (FY, 2016)
Revenue (est.)
$132.3m (FY, 2020)
Revenue (est.)
$100.4m (FY, 2020)
Revenue (est.)
€7.8m (FY, 2020)
Net income
Net income
(€1.1m) (FY, 2016)
Net income
($44.4m) (FY, 2020)
Net income
($32.9m) (FY, 2020)
Net income
(€101.2m) (FY, 2020)

Operating

Patents (Foreign)
Patents (Foreign)
180 (Q2, 2017)
Patents (Foreign)
N/A
Patents (Foreign)
4 (FY, 2016)
Patents (Foreign)
450 (FY, 2019)
Patents (US)
Patents (US)
50 (Q2, 2017)
Patents (US)
N/A
Patents (US)
13 (FY, 2016)
Patents (US)
28 (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 498.8m
Total funding raised
$ 56m
Total funding raised
$ 132.4m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

ImmunoGen
HQ
Waltham, US
Employees
79↑ 5% increase

ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.

View company
CytomX Therapeutics
HQ
South San Francisco, US
Employees
158↑ 15% increase

CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.

View company
Genfit
HQ
Loos, FR
Employees
130

GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.

View company